Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2006
05/24/2006CN1775228A Method for preparing Chinese medicine for antibacterial and anti-inflammation and its quality control technology
05/24/2006CN1775227A Ointment medicine for treating bedsore
05/24/2006CN1775225A Thyroxine liothyronine eyedrops
05/24/2006CN1775223A Compound arsenic trioxide injection
05/24/2006CN1775222A Saline solution for treating nasal cavity disease and its application device
05/24/2006CN1775219A Medicinal formulation for preventing and treating ischemic vascular disease, and its preparing method and use
05/24/2006CN1775218A Cyclophosphamide liposome and its preparing method
05/24/2006CN1775216A New formulation oxaliplatin liposome
05/24/2006CN1775215A Azasetron hydrochloride glucose injection formulation, and its preparing method and quality control technology
05/24/2006CN1775214A Rifapentine, refampicin, rifabutin or rifamdin injection and its preparing method
05/24/2006CN1775212A Use of pirfenidone for treating psoriasis
05/24/2006CN1775210A Ftibamzone eyedrops
05/24/2006CN1775209A Magnetic target slow-release catopril and its preparing method
05/24/2006CN1775208A Liver-tonifying formulation prepared from silymarin and its preparing method
05/24/2006CN1775207A Esmolol formulation
05/24/2006CN1775206A Phacolysin eye medicinal formulation
05/24/2006CN1775057A Process for preparing cold tea paste
05/24/2006CN1257176C Application of 2,3,5,4'-tetrahydroxy diphenyl ethylene-2-1-beta-D-glucoside for preparation of drug reducing blood fat
05/24/2006CN1257011C Lipid nanocapsules, preparation method and use as medicine
05/24/2006CN1256985C Method for manufacturing chitosan capillary and application thereof
05/24/2006CN1256984C Isulin solid granular, its preparation method and its use in preparing medicine for treating diabetes
05/24/2006CN1256983C Use of mannan peptide in preparation of immunologic enhancement medication which is topically and orally applicated
05/24/2006CN1256979C Traditional Chinese medicinal prepn. capsule for treating presistent febris during common cold
05/24/2006CN1256976C Anti-cancer Chinese medicinal composition and its preparing method
05/24/2006CN1256974C Compound formula chinaroot greenbrier granules and its preparation method
05/24/2006CN1256973C Compound formula chinaroot greenbrier tablet and its preparation method
05/24/2006CN1256970C Naristillae for curing rhinopathy
05/24/2006CN1256968C Plaster for treating bone disease
05/24/2006CN1256966C Traditional Chinese medicinal ointment for treaing burns and scald
05/24/2006CN1256959C Rhinitis treating medicinal cream
05/24/2006CN1256955C Chinese medicine composition for curing cancer and its preparing method
05/24/2006CN1256954C Argyi leaf oil dripping pills and its preparation process
05/24/2006CN1256951C Use of sea dog soft capsule in preparing health products for dispelling chloasma
05/24/2006CN1256949C Notoginsen total saponin plastid and prepartion thereof
05/24/2006CN1256948C Avermectin containing parasite resisitant long-acting injection
05/24/2006CN1256945C Suppository for treating cancer pain and its preparation method
05/24/2006CN1256944C Preparation method of captopril compounding chitosan slow release micro ball
05/24/2006CN1256943C Stable ascorbic acid inorganic salt liquid composition, its preparation method and applications
05/24/2006CN1256940C Compound Chinese medicine notoginseng dripping pills and its preparation process
05/24/2006CN1256939C Coenzyme Q10 containing microemulsion preconcentrates and microemulsions
05/23/2006USRE39104 Dissolving a mixture of progesterone and estradiol, hydrophilic polymer carrier in a volatile organic solvent, evaporting to desolventize, precipitating to form powders; mouth administering, fast and great resorption; hormone replacement therapy, hormonal insufficiency
05/23/2006US7049479 Ultra thin film transdermal/dermal or transmucosal/mucosal delivery system
05/23/2006US7049430 Method of treating HIV infection and related secondary infections thereof
05/23/2006US7049407 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer
05/23/2006US7049360 Water-soluble or water-dispersible (co) polymers of hydroxyalkyl (meth) acrylates, a process for their preparation, and their use as coating agent, binder and/or film-forming excipient pharmaceutical dosage forms
05/23/2006US7049348 Porous polymer network and modeling agent
05/23/2006US7049339 comprises zinc sulphate, copper sulphate, an organic acid, an alkali metal salt; more effective at applying an active ingredient to a hoof than a conventional, non-colloid system; treatment of digital dermatitis
05/23/2006US7049293 Peptide and osteogenetic accelerator
05/23/2006US7049283 Pharmaceutical compositions for the oral delivery of pharmacologically active agents
05/23/2006US7049152 Color and shape changing polymeric ribbons and sheets
05/23/2006US7049078 Apolipoprotein E polymorphism and treatment of alzheimer's disease
05/23/2006US7048951 applying mixtures of sodium nitrite, ascorbic acid and maleic acid, that generate nitric oxide on treatment with water, in the form of ointments for controlled release
05/23/2006US7048950 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications and preparations
05/23/2006US7048949 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports
05/23/2006US7048948 Stable granulates containing S-adenosylmethionine and process for the preparation thereof
05/23/2006US7048947 Sustained-release preparation
05/23/2006US7048946 Formulation for controlled release of drugs by combining hyrophilic and hydrophobic agents
05/23/2006US7048945 Timed pulsatile drug delivery systems
05/23/2006US7048944 Generation of sealed vesicle; obtain dehydrated micelle, incubate in rehydration soluton at low temperature, recover sealed micelles
05/23/2006US7048943 Carotenoid-loaded liposomes
05/23/2006US7048941 Chocolate composition as delivery system for nutrients and medications
05/23/2006US7048914 Placental alkaline phosphatase to control diabetes
05/23/2006US7048909 Aerosols containing nondegraded atenolol, pindolol, esmolol, propranolol, or metoprolol
05/23/2006US7048908 Particles for inhalation having sustained release properties
05/23/2006US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
05/23/2006US7048730 Temperature activated systems
05/23/2006US7048729 Catheter and method of fluid removal from a body cavity
05/23/2006US7048543 A shaped dental bleaching device contains adhesion agent for increasing adhesion to teeth when moistened by saliva or water; polyvinyl pyrrolidone adhesives; kits; dentistry
05/23/2006CA2428870C Freeze-dried pantoprazole preparation and pantoprazole injection
05/23/2006CA2312729C Use of 9-deoxy-2', 9-.alpha.-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
05/23/2006CA2263921C Oral delayed immediate release formulation and method of preparation therefor
05/23/2006CA2245206C Use of an inhibitor of excitatory amino acids in a cosmetic or dermatological compound for sensitive skin, and the compound thus obtained
05/23/2006CA2235413C Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers
05/23/2006CA2227792C Polymeric drug formulations
05/23/2006CA2071974C Vaccine compositions for fish
05/18/2006WO2006053225A2 Protein-noble metal nanoparticles
05/18/2006WO2006053175A2 A stabilized polymeric delivery system
05/18/2006WO2006053170A1 Sugars and/or sugar alcohols for inhibiting and/or treating vaginal infection
05/18/2006WO2006053164A2 Ophthalmic solution
05/18/2006WO2006053150A2 Pharmaceutical compositions for topical application on the treatment of age-related macular degeneration and ocular hypertension
05/18/2006WO2006053089A2 Methods and formulations for making pharmaceutical compositions containing bupropion
05/18/2006WO2006053056A2 Liquid, gas and/or vapor phase delivery systems
05/18/2006WO2006053006A2 Retinoid solutions and formulations made therefrom
05/18/2006WO2006052968A2 Stabilized ramipril compositions and methods of making
05/18/2006WO2006052921A2 Cyclodextrin solubilizers for liquid and semi-solid formulations
05/18/2006WO2006052887A1 Formulations of [1,4]diazepino[6,7,1-ij]quinoline derivatives
05/18/2006WO2006052767A2 Compositions and methods for stabilizing liposomal camptothecin formulations
05/18/2006WO2006052763A2 Compression and cold weld sealing methods and devices
05/18/2006WO2006052734A1 Liposome formulation of peptide boronic acids compounds
05/18/2006WO2006052733A1 Liposomal formulation of bortezomib (ps-341)
05/18/2006WO2006052712A1 Nanoparticulate compositions of tubulin inhibitor
05/18/2006WO2006052649A2 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
05/18/2006WO2006052598A2 Vinyl amide-containing adhesive compositions for plastic bonding, and methods and products utilizing same
05/18/2006WO2006052461A2 Novel formulations of eprosartan with enhanced bioavailability
05/18/2006WO2006052454A1 Propranolol formulations
05/18/2006WO2006052452A1 Non-gelatin soft capsule system
05/18/2006WO2006052405A1 Propranolol formulations
05/18/2006WO2006052098A1 The injection of tacrolimus
05/18/2006WO2006052018A1 Aqueous ophthalmic suspension of crystalline rebamipide
05/18/2006WO2006051819A1 Drug for external use and adhesive patch